Solutions for Functional Proteomics

News and Events

PLEXERA to Exhibit at the 2nd International Conference on Label-Free Technologies - Boston March 12-14 2015


Plexera will be exhibiting the PlexArray HT at Boston's Label-Free Technologies conference March 12-14 at the Cambridge Marriott. Come visit booth 5 for information on how Plexera can facilitate your high-throughput label-free workflow with our innovative SPRi instrument and research service offerings.

2nd International Conference on Label-Free Technologies

JPT and PLEXERA Announce Distribution & Collaboration Agreement


Guangzhou, China - February 17th, 2015. Plexera Biotechnology Ltd., exclusively representing Plexera LLC, and JPT Peptide Technologies GmbH, a wholly-owned subsidiary of BioNTech AG, today announced finalization of a distribution and collaboration agreement. The agreement provides for distribution of JPT’s innovative peptide-based products and services to the Chinese immunotherapy, vaccine and proteomics markets. Furthermore, the partnership promotes the development of peptide-based applications on the PlexArray® HT, Plexera’s high-throughput proteomics screening platform. “This partnership represents a strategic cornerstone in our continued efforts to address all major global markets with our broad portfolio of proprietary and high quality products for the discovery of novel biomarkers and the development of immunotherapies and vaccines” said Holger Wenschuh, CEO of JPT. He added, “Plexera proved to be the ideal partner for our goals as they not only understand the challenge of explaining complex products for high level biomedical applications but also possess a decade long track record of effectively approaching the Chinese market and its opportunities”. Jingsong Zhu, CEO of Plexera commented: “JPT’s high performance peptide tools and services for applications in rapidly developing biotechnology arenas represent an optimal complement to our own functional proteomics solutions, including our unique PlexArray Technology. We trust that Chinese customers will appreciate the joint efforts to make these products readily available.”

Full press release

PLEXERA® Launches Lectin Array Chip


Woodinville, Washington – June 24, 2013 – Plexera®, LLC, a worldwide provider of label-free surface plasmon resonance imaging (SPRi) technology solutions for functional proteomics, announced today the launch of the Lectin Array Chip for high throughput glycoprofiling and biomarker discovery. The Lectin Array Chip leverages the PlexArray® HT's high throughput, label-free, SPRi platform for rapid characterization and quantification of glycosylation in protein samples. Dysregulation of glycoprotein is associated with a wide range of diseases including diabetes, cardiovascular disease, and cancer. The detection of deregulated glycosylation has been recognized as a hallmark for cancer biomarker discovery; however, the complexity of the glycome can be a challenge to comprehensive research in this field. The Lectin Array Chip is the first of its kind to provide researchers tools to sort the complexity of the glycome.

Click here for Lectin Array Chip press release

PLEXERA® Launches Contract Research Services Business

Seattle, Washington – January 14, 2013 – Plexera®, LLC, a worldwide provider of label-free surface plasmon resonance imaging (SPRi) technology solutions for functional proteomics, announced today the official launch of its contract research effort based at the Institute for Systems Biology(ISB) in offices of Plexera LLC. We will perform advanced kinetic interaction analysis on either customer provided samples or Plexera provided targets and libraries.

Click here for PlexArray® Contract Research Services Press Release

Shipments and Patents

The company also announced it has manufactured and shipped its 18th PlexArray® HT system since launched in 2011 and has been awarded its 11th patent surrounding the SPRi technology. “We are very pleased with the depth of our patent portfolio and the ever increasing inventory of application developments we have made over the last year.” Says Dr. Jinsong Zhu, CEO, Plexera LLC. “As indicated by customer interest the HT application for interaction studies is certainly an emerging commercial technology today.”

Plexera Launches the PlexArray® HT System

Plexera launched its flagship product, the PlexArray® HT System at the past Society for Biomolecular Sciences (SBS) conference in Orlando, Florida and the 2012 SLAS conference in San Diego, California. A working model of the system was featured and both events were very successful for the company in its efforts to build awareness of the system and their best-in-class high throughput SPR technology.
Click here for Poster Presentation from SLAS
Click here for PlexArray® HT Press Release

February 15, 2011 - PLEXERA interview published in Genetic Engineering & Biotechnology News

GEN Engineering News publishes article about current SPR technologies and applications. Read the full article about advances in SPR technology on line at

About This Site | Privacy Policy | Site Map | Terms and Conditions | Contact Us | © 2008-2018 Plexera® Bioscience.